Purchase Order 36C24518P2344
- Not listed
- This is a $76,548.40 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Walgreen Co., doing business as Walgreens, for the delivery of LEMTRADA injections. The contract has no set-aside designation and was awarded on July 1, 2018, with a completion date of July 2, 2018. Walgreens is a major federal contractor and grant recipient, leveraging its nationwide network of retail pharmacies to support various federal healthcare initiatives, including COVID-19...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $51.8 million firm fixed price delivery order contract to Walgreen Co., doing business as Walgreens, to provide retail pharmacy influenza immunization services. Under this contract, Walgreens will administer influenza vaccinations to veterans across its locations in Riverwoods, Illinois. The contract runs from August 1, 2019 through March 31, 2020. As the nation's largest retail...
- This is a new task order awarded to Walgreen Co. (Walgreens) under a multi-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Department of Health and Human Services (HHS) for vaccination services. The task order, valued at $40,024.60, provides HHS with access to a variety of vaccination solutions to assist in the voluntary administration of influenza and COVID-19 vaccines to multiple populations. The contract has a period of performance through November 23, 2024 and utilizes...
- This federal contract award for Occupational Health Services was issued by an unnamed government agency to Hummer Whole Health Management, Inc., a subsidiary of Walgreen Co. (Walgreens). The contract has a ceiling value of $1,175,365.00 and a period of performance ending on March 31, 2006. It is a firm fixed-price delivery order contract with no set-aside designation. Walgreens, the largest pharmacy health and daily living retailer in the U.S., has a substantial presence in the federal...
- This federal contract award, valued at $12,580.72, was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the broader Walgreens retail pharmacy chain. The contract is a firm fixed price purchase order for the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is one of several similar contracts Walgreens Specialty Pharmacy has received from...
- The Indian Health Service awarded a Blanket Purchase Agreement (BPA) call valued at $19,301.59 to Walgreen CO. (doing business as Walgreens) on May 12, 2023, with a completion date of September 30, 2023. This firm fixed-price contract, to be performed in Mashpee, Massachusetts, represents a de-obligation of remaining funds from an expired BPA. The award utilized no small business set-aside designation, with Walgreens competing as a large prime contractor. This award is consistent with IHS's...
- This federal contract award is for the delivery of LEMTRADA INJECTION VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract was awarded to Genzyme Corporation, doing business as Sanofi Genzyme, a global healthcare and pharmaceutical company. It is a firm fixed price delivery order under Genzyme's $659 million Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows the VHA to issue task orders for a...
- Walgreen Co. was awarded a firm fixed price blanket purchase agreement (BPA) call contract from the Department of Health and Human Services Indian Health Service for pharmaceutical services for the Mid-Atlantic Service Unit for the month of March. The contract has a potential value of $58,635.67 and period of performance through September 30, 2021. Walgreen Co. will provide pharmaceutical products and services to support the Indian Health Service's healthcare programs for Native American...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,647.20 firm fixed-price delivery order is for the supply of the vaccine VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, issued by the Defense Logistics Agency (DLA), provides for the delivery of OCREVUS 300 mg/10 ml vials to the government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $23,118.08. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Walgreen Co. (Walgreens) for LEMTRADA IV injections. The contract has a ceiling value of $76,548.40 and a firm fixed price pricing type, with an ultimate completion date of April 2, 2018. The contract was not set aside for any specific business type. Walgreens, a major pharmacy health and daily living retailer, has been awarded several federal contracts and grants to provide COVID-19 testing and vaccination services, as well as other pharmaceutical products and outpatient pharmacy services, to various agencies including the Department of Health and Human Services, Centers for Disease Control and Prevention, Department of Homeland Security, and Indian Health Service. This contract appears to be part of Walgreens' broader work supporting federal healthcare initiatives and delivering critical medical countermeasures and services to underserved communities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.5k | 3/6/18 |